Senior insider sale
Chief Financial Officer at UROGEN PHARMA LTD. — senior position signals high conviction
$89.6K
2.20K shares
What this filing means
DEGNAN CHRIS plans to sell 2.20K shares of UROGEN PHARMA LTD. valued at approximately $89.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/9/2026ACC: 0001976408-26-000887
Officer· Chief Financial Officer
Since Jan 2026
2.20K
Shares to sell
$89.6K
Approx. market value
8.97K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Shares issued upon vesting of RSUs
No consideration, shares issued upon vesting of RSUs
10/8/2026
8.97KTotal acquired8.97K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/8/2026 | Shares issued upon vesting of RSUs No consideration, shares issued upon vesting of RSUs | 8.97K | — |
| Total | 8.97K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
2.20K
Market value
$89.6K
10/8/2026
Total
Units
2.20K
Value
$89.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/8/2026 | 2.20K | $89.6K | Nasdaq | Planned |
| Total | 2.20K | $89.6K | ||